See more details in the attached Job Description (JD). 1 OVERALL OBJECTIVES: 1.1 To focus on in the creation of a robust framework to facilitate the early and successful implementation of identified upcoming biosimilars, enabling the Trust to maximize cost efficiencies while maintaining high standards of patient care. 1.2 To deputise for the chair of the Best Value Medicines and Biologics Group (BVMB). BVMB will be a subgroup of the Trusts Medicines Management and Therapeutics Committee. Its main function would be to ensure the cost-effective use of biologic medicines and to coordinate the savings plan on biologics and other high-cost medicines, especially biosimilars and other high-cost medicines that have their patient expired. 1.3 To support the Biologics and Medicine Value Lead pharmacists by promoting and facilitating best value in the use of HCD with a particular focus on biologic medicines (including biosimilars) ensuring best value, reduced harm and improved outcomes from the significant investment in medicines. 1.4 To play a key role in implementing savings initiatives relating to biologics, for example, introducing new biosimilar products into the Trust. 1.5 To identify savings opportunities relating to biologic medicines and implement a program of projects to achieve the savings. The Senior Pharmacy Management Team, The Medicines Effectiveness Team, NHSE Specialised Commissioning Pharmacy Team and BOB ICB Medicines Optimisation Team will support this. 1.6 To work as part of the Trusts Best Value Medicines and Biologics and Medicines Effectiveness teams to achieve the Trust's Medicines Optimisation strategy in relation to the clinical and cost-effective use of medicines within the Trust. 1.7 To work with the OUH Medicines homecare team to optimise the use of homecare for biologics and other high-cost medicines. 1.8 To work collaboratively alongside Commissioning Pharmacists to deliver the best value from the use of HCDs by supporting cost saving initiatives. 1.12 To attend and/or provide information for appropriate prescribing committee meetings such as the Trusts Medicines Management Therapeutics Committee (MMTC), Cost Effective Use of Medicines Group, Homecare User Group, as well as BOB ICBs High-Cost Drugs Group, NHSE High-Cost Drugs, Medicines Optimisation Collaborative Leadership Group (MOCL), as well as other OUH and stakeholder meetings as needed.